Health Care Select Sector SPDR (XLV)
71.38
-1.28 -1.76%
NYSE Arca
Sep 29, 20:00
Delayed 2m
USD
XLV Key Stats
| Expense Ratio | 0.14% |
| Share Class Assets Under Management | 12.40B |
| 30-Day Average Daily Volume | Upgrade |
| Net Asset Value | 71.36 |
| Discount or Premium to NAV | 0.03% |
| Turnover Ratio | 3.25 |
View All XLV News
XLV News
-
WireHeadlineTime (ET)
-
MT Newswires09/29 13:23
-
MT Newswires09/29 09:21
-
MT Newswires09/28 13:18
-
MT Newswires09/28 09:11
-
MT Newswires09/27 13:16
-
MT Newswires09/27 09:17
-
MT Newswires09/26 13:16
-
MT Newswires09/26 09:16
-
MT Newswires09/23 13:27
-
MT Newswires09/23 09:11
XLV Performance
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | Cat. Total Return (Price) | % Rank in Cat. (Price) | |
|---|---|---|---|---|---|
| 1M | -2.15% | 3.39% | 90 | 3.32% | 94 |
| 3M | 0.87% | 11.79% | 79 | 11.47% | 82 |
| 6M | 5.84% | 17.10% | 76 | 16.84% | 76 |
| 1Y | 11.76% | 7.98% | 26 | 8.28% | 19 |
| 3Y | 47.15% | 13.05% | 35 | 13.10% | 29 |
| 5Y | 141.4% | 20.28% | 56 | 20.28% | 53 |
XLV Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.03% | 0.03% | 0.00 |
| Stock | 99.97% | 99.97% | 0.00 |
| Bond | 0.00 | 0.00 | 0.00 |
| Convertible | 0.00 | 0.00 | 0.00 |
| Preferred | 0.00 | 0.00 | 0.00 |
| Other | 0.00 | 0.00 | 0.00 |
XLV Region Exposure
| Americas | 100.0% |
| North America | 100.0% |
| Latin America | 0.00 |
| Greater Europe | 0.00 |
| United Kingdom | 0.00 |
| Europe Developed | 0.00 |
| Europe Emerging | 0.00 |
| Africa/Middle East | 0.00 |
| Greater Asia | 0.00 |
| Japan | 0.00 |
| Australasia | 0.00 |
| Asia Developed | 0.00 |
| Asia Emerging | 0.00 |
| Market Classification | |
| % Developed Markets | 100.0% |
| % Emerging Markets | 0.00 |
Region breakdown data is calculated by using the long position holdings of the portfolio.
XLV Stock Sector Exposure
| Basic Materials | 0.00 |
| Communication Services | 0.00 |
| Consumer Cyclical | 0.00 |
| Consumer Defensive | 0.00 |
| Energy | 0.00 |
| Financial Services | 0.00 |
| Healthcare | 97.63% |
| Industrials | 1.69% |
| Real Estate | 0.00 |
| Technology | 0.67% |
| Utilities | 0.00 |
XLV Stock Market Capitalization
| Giant | 59.25% |
| Large | 33.25% |
| Medium | 7.50% |
| Small | 0.00 |
| Micro | 0.00 |
XLV Stock Style Exposure
| Large Cap Value | 9.49% |
| Large Cap Blend | 27.27% |
| Large Cap Growth | 55.74% |
| Mid Cap Value | 0.60% |
| Mid Cap Blend | 4.12% |
| Mid Cap Growth | 2.78% |
| Small Cap Value | 0.00 |
| Small Cap Blend | 0.00 |
| Small Cap Growth | 0.00 |
View More Holdings
As of Sept. 28, 2016
XLV Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 11.72% | 117.27 | -1.78% |
| PFE | Pfizer Inc | 7.40% | 33.32 | -1.97% |
| MRK | Merck & Co Inc | 6.28% | 61.91 | -2.20% |
| UNH | UnitedHealth Group Inc | 4.84% | 138.32 | -1.49% |
| AMGN | Amgen Inc | 4.56% | 165.45 | -2.51% |
| MDT | Medtronic PLC | 4.32% | 85.40 | -1.54% |
| ABBV | AbbVie Inc | 3.75% | 62.82 | -2.18% |
| GILD | Gilead Sciences Inc | 3.74% | 77.86 | -1.41% |
| AGN | Allergan PLC | 3.56% | 230.80 | -2.94% |
| BMY | Bristol-Myers Squibb Company | 3.32% | 53.87 | -2.21% |
Advertisement
One Page Reports
- One Page Report Download
XLV Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Benchmark Index | |
|---|---|
S&P Health Care Select Sector TR USD |
100.0% |
XLV Manager Info
| Name | Tenure |
|---|---|
| John Tucker | 16.59 yrs |
| Karl Schneider | 1.58 yrs |
| Michael Feehily | 5.59 yrs |
XLV Net Fund Flows
| 1M | -30.01M |
| 3M | 50.89M |
| 6M | -570.74M |
| YTD | -1.057B |
| 1Y | -1.661B |
| 3Y | 2.134B |
| 5Y | 3.947B |
| 10Y | 5.289B |
XLV Risk Info
| Beta | 0.8313 |
| Max Drawdown (All) | 40.51% |
| Historical Sharpe (10Y) | 0.7639 |
| Historical Sortino (All) | 0.6846 |
| 30-Day Rolling Volatility | 12.96% |
| Daily Value at Risk (VaR) 1% (All) | 3.08% |
| Monthly Value at Risk (VaR) 1% (All) | 13.23% |
XLV Fundamentals
| Dividend Yield TTM (9-29-16) | 1.55% |
| Weighted Average PE Ratio | 22.24 |
| Weighted Average Price to Sales Ratio | 1.778 |
| Weighted Average Price to Book Ratio | 3.649 |
| Weighted Median ROE | 21.09% |
| Weighted Median ROA | 8.16% |
| Forecasted Dividend Yield | 1.69% |
| Forecasted PE Ratio | 19.86 |
| Forecasted Price to Sales Ratio | 1.703 |
| Forecasted Price to Book Ratio | 3.125 |
| Number of Holdings | 60 |
XLV Growth Estimates
| Forecasted 5 Yr Earnings Growth | 10.02% |
| Forecasted Book Value Growth | 10.28% |
| Forecasted Cash Flow Growth | 6.43% |
| Forecasted Earnings Growth | 7.37% |
| Forecasted Revenue Growth | 10.28% |
XLV Comparables
EditXLV Attributes
| Key Dates | |
|---|---|
| Inception Date | 12/16/1998 |
| Last Annual Report Date | 9/30/2015 |
| Last Prospectus Date | 9/2/2016 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | Yes |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
XLV Excel Add-In Codes
- Name: =YCI("XLV","name")
- Broad Asset Class: =YCI("XLV", "broad_asset_class")
- Broad Category: =YCI("XLV", "broad_category_group")
- Prospectus Objective: =YCI("XLV", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement